相似文献
1
Induction of high STAT1 expression in transgenic mice with LQTS and heart failure.
Biochem Biophys Res Commun. 2007 Jun 29;358(2):449-54. doi: 10.1016/j.bbrc.2007.04.119. Epub 2007 Apr 26.
2
LQTS mutation N1325S in cardiac sodium channel gene SCN5A causes cardiomyocyte apoptosis, cardiac fibrosis and contractile dysfunction in mice.
Int J Cardiol. 2011 Mar 3;147(2):239-45. doi: 10.1016/j.ijcard.2009.08.047. Epub 2009 Sep 17.
3
Optical mapping of ventricular arrhythmias in LQTS mice with SCN5A mutation N1325S.
Biochem Biophys Res Commun. 2007 Jan 26;352(4):879-83. doi: 10.1016/j.bbrc.2006.11.106. Epub 2006 Dec 1.
4
Mutation analysis in congenital Long QT Syndrome--a case with missense mutations in KCNQ1 and SCN5A.
Genet Test. 2003 Spring;7(1):57-61. doi: 10.1089/109065703321560958.
5
Functional suppression of Kcnq1 leads to early sodium channel remodelling and cardiac conduction system dysmorphogenesis.
Cardiovasc Res. 2013 Jun 1;98(3):504-14. doi: 10.1093/cvr/cvt076. Epub 2013 Mar 29.
6
Cardiac-specific overexpression of SCN5A gene leads to shorter P wave duration and PR interval in transgenic mice.
Biochem Biophys Res Commun. 2007 Apr 6;355(2):444-50. doi: 10.1016/j.bbrc.2007.01.170. Epub 2007 Feb 7.
7
Regulation of myocardial interleukin-6 expression by p53 and STAT1.
J Interferon Cytokine Res. 2013 Sep;33(9):542-8. doi: 10.1089/jir.2012.0165. Epub 2013 May 15.
8
[Molecular genetics in the hereditary form of long QT syndrome].
Med Pregl. 2000 Jan-Feb;53(1-2):51-4.
9
A novel SCN5A mutation manifests as a malignant form of long QT syndrome with perinatal onset of tachycardia/bradycardia.
Cardiovasc Res. 2004 Nov 1;64(2):268-78. doi: 10.1016/j.cardiores.2004.07.007.
10
A revised view of cardiac sodium channel "blockade" in the long-QT syndrome.
J Clin Invest. 2000 Apr;105(8):1133-40. doi: 10.1172/JCI9212.
引用本文的文献
1
Molecular Mechanism of Yangshen Maidong Decoction in the Treatment of Chronic Heart Failure based on Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulations.
Cell Biochem Biophys. 2024 Jun;82(2):1433-1451. doi: 10.1007/s12013-024-01297-7. Epub 2024 May 16.
2
Biophysical mechanisms of myocardium sodium channelopathies.
Pflugers Arch. 2024 May;476(5):735-753. doi: 10.1007/s00424-024-02930-3. Epub 2024 Mar 1.
3
Study on Potential Differentially Expressed Genes in Idiopathic Pulmonary Fibrosis by Bioinformatics and Next-Generation Sequencing Data Analysis.
Biomedicines. 2023 Nov 21;11(12):3109. doi: 10.3390/biomedicines11123109.
4
CCND1 Overexpression in Idiopathic Dilated Cardiomyopathy: A Promising Biomarker?
Genes (Basel). 2023 Jun 10;14(6):1243. doi: 10.3390/genes14061243.
5
Identification of biomarkers, pathways, and potential therapeutic targets for heart failure using next-generation sequencing data and bioinformatics analysis.
Ther Adv Cardiovasc Dis. 2023 Jan-Dec;17:17539447231168471. doi: 10.1177/17539447231168471.
6
Identification of potentially relevant genes for myocardial infarction using RNA sequencing data analysis.
Exp Ther Med. 2018 Feb;15(2):1456-1464. doi: 10.3892/etm.2017.5580. Epub 2017 Nov 28.
7
Nemo-Like Kinase (NLK) Is a Pathological Signaling Effector in the Mouse Heart.
PLoS One. 2016 Oct 20;11(10):e0164897. doi: 10.1371/journal.pone.0164897. eCollection 2016.
8
Coherent functional modules improve transcription factor target identification, cooperativity prediction, and disease association.
PLoS Genet. 2014 Feb 6;10(2):e1004122. doi: 10.1371/journal.pgen.1004122. eCollection 2014 Feb.
9
LQTS mutation N1325S in cardiac sodium channel gene SCN5A causes cardiomyocyte apoptosis, cardiac fibrosis and contractile dysfunction in mice.
Int J Cardiol. 2011 Mar 3;147(2):239-45. doi: 10.1016/j.ijcard.2009.08.047. Epub 2009 Sep 17.
本文引用的文献
1
Transcription protein STAT1: biology and relation to cancer.
Folia Biol (Praha). 2007;53(1):1-6.
2
Cardiac-specific overexpression of SCN5A gene leads to shorter P wave duration and PR interval in transgenic mice.
Biochem Biophys Res Commun. 2007 Apr 6;355(2):444-50. doi: 10.1016/j.bbrc.2007.01.170. Epub 2007 Feb 7.
3
Optical mapping of ventricular arrhythmias in LQTS mice with SCN5A mutation N1325S.
Biochem Biophys Res Commun. 2007 Jan 26;352(4):879-83. doi: 10.1016/j.bbrc.2006.11.106. Epub 2006 Dec 1.
4
Characterization of the cardiac sodium channel SCN5A mutation, N1325S, in single murine ventricular myocytes.
Biochem Biophys Res Commun. 2007 Jan 12;352(2):378-83. doi: 10.1016/j.bbrc.2006.11.019. Epub 2006 Nov 14.
5
Sodium channel mutations and susceptibility to heart failure and atrial fibrillation.
JAMA. 2005 Jan 26;293(4):447-54. doi: 10.1001/jama.293.4.447.
6
Expression profiling of cardiovascular disease.
Hum Genomics. 2004 Aug;1(5):355-70. doi: 10.1186/1479-7364-1-5-355.
7
Post-transcriptional alterations in the expression of cardiac Na+ channel subunits in chronic heart failure.
J Mol Cell Cardiol. 2004 Jul;37(1):91-100. doi: 10.1016/j.yjmcc.2004.04.003.
8
STAT-1: a novel regulator of apoptosis.
Int J Exp Pathol. 2003 Dec;84(6):239-44. doi: 10.1111/j.0959-9673.2003.00363.x.
9
Mechanisms by which SCN5A mutation N1325S causes cardiac arrhythmias and sudden death in vivo.
Cardiovasc Res. 2004 Feb 1;61(2):256-67. doi: 10.1016/j.cardiores.2003.11.007.
10
Identification of new genes differentially expressed in coronary artery disease by expression profiling.
Physiol Genomics. 2003 Sep 29;15(1):65-74. doi: 10.1152/physiolgenomics.00181.2002.
Zotero 插件